← All companies
BridgeBio Pharma, Inc.
BBIO - CIK 0001743881
Market cap$13.20 B
Rank#791
SEC filings777
Market capitalization of BridgeBio Pharma, Inc.
As of 2026-06-11, BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $13.20 B, making it the #791 most valuable US-listed company.
Recent market cap readings
| Date | Market cap |
|---|---|
| 2026-06-11 | $13.20 B |
| 2026-06-10 | $13.20 B |
| 2026-05-29 | $13.20 B |
| 2026-05-28 | $13.01 B |
| 2026-05-26 | $13.19 B |
| 2026-05-25 | $13.54 B |
| 2026-05-24 | $13.54 B |
| 2026-05-22 | $13.54 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
Market Cap of similar companies
Frequently asked questions
What is BridgeBio Pharma, Inc.'s market cap?
As of 2026-06-11, BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $13.20 B, making it the #791 most valuable US-listed company.
Where does BridgeBio Pharma, Inc. rank by market cap?
BridgeBio Pharma, Inc. is the #791 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.